OA01.06 First-Line Chemotherapy With or Without Tislelizumab for Extensive-Stage Small Cell Lung Cancer: RATIONALE-312 Phase 3 Study

Yi-Kan Cheng, Yun Fan, Yao Zhao, Dabing Huang, Xun Li, Peihong Zhang, Mingu Kang, Ning Yang, Dingyong Zhong, Zheng Wang, Yan Yu, Ying Zhang, Jun Zhao, T J Qin, Chang Chen, Shiang Jiin Leaw, Wenling Zheng, Yong Song